Multiple Sclerosis (MS) is a progressive disorder impacting the central nervous system (CNS). Given the severity of the disorder and the fact that there is no known cure, it is critical for physicians to have additional options for treating their patients. This petition requests the expedited approval for innovative new treatments for MS. Specifically, we ask that MS patients get to choose whether or not to take alemtuzumab because it is a safe and effective treatment option for some people suffering from MS. Existing therapies are not meeting the needs of current patients. These patients do not want to wait for either future therapies or the completion of additional trials for alemtuzumab.
Alemtuzumab should be approved so MS doctors and their patients have a new treatment choice.